8/12/2019 FDA Series 2 letters on Safety of Contraceptives

1/18

07 July 2014

D R . K ENNETH Y. H ARTIGAN G ODirector GeneralPhilippine Food and Drug AdminstrationCivic Drive, Filinvest Corporate City

Alabang, Muntinlupa City

M S . A GNETTE P. P ERALTADirector IVCenter for Device Regulation,Radiation Health and ResearchFood and Drug Adminstration

A TTY . D ONNA M AY P. S ANCHEZLegal Services Support CenterFood and Drugs Administration

Re: ADVERSE EFFECTS OF METHODS OF FAMILY PLANNING ON WOMENSHEALTH-----------------------------------------------------------------------------------------------

Dear Mr. Secretary and Gentlemen:

We bring to your attention documented reports of damage suits againstmajor pharmaceutical companies and the million-dollar settlements favoringconsumers of their family planning/birth control products:

$700M CLASS SUIT SAYS DEPO-PROVERA CAUSESOSTEOPOROSIS 1 (Annex A)

43 WOMEN SUE OVER BIRTH CONTROL PATCH 2 (Annex B)

J&J PAID $68M TO SETTLE BIRTH CONTROL CASES 3 (Annex C)

---------------------------------------------------1 http://www.lifesitenews.com/news/archive/ldn/2005/dec/051221012 http://www.lifesitenews.com/news/archive/ldn/2006/nov/061102063 http://www.bloomberg.com/apps/news?pid=newsarchive&sid=amZT0X84_8zU&refer=home

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

2/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

3/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

4/18

H ON . E NRIQUE T. O NASecretaryPhilippine Department of Health (DOH)San Lazaro Compound, City of Manila; and:

H ON . J ANETTE L. G ARINUndersecretaryWomen, Children and Family Health Cluster

D R . E LMER G. P UNZALAN Assistant SecretaryOffice for Special Concerns

D R . I VANHOE C. E SCARTINOIC, Director IVNational Center for Health Promotion

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

5/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

6/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

7/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

8/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

9/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

10/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

11/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

12/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

13/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

14/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

15/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

16/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

17/18

8/12/2019 FDA Series 2 letters on Safety of Contraceptives

18/18